Immunicum’s CSO Alex Karlsson-Parra awarded the Athena

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Immunicum’s CSO Alex Karlsson-Parra awarded the Athena Prize

Gothenburg, Sweden, 2014-11-26 08:30 CET (GLOBE NEWSWIRE) -- Immunicum AB (publ) today announced that the company's founder and Chief Scientific Officer, Alex Karlsson-Parra, has been awarded the Athena Prize for his creative and innovative development of therapeutic cancer vaccines, which constitutes the core of Immunicum’s business.

Dr. Alex Karlsson-Parra is Chief Scientific Officer at Immunicum and Chief Physician at Uppsala University Hospital. Together with his colleagues, he has devoted 15 years of research to the development of a therapeutic cancer vaccine, based on activation of the patient's own tumor-specific immune response by exposure to non-endogenous immune cells. Unlike other cancer vaccines that use the patient's own immune cells, this innovative concept implies the use of white blood cells from healthy blood donors. Immune cells are cultivated to dendritic cells that are activated by an immunological shock treatment. After activation, the cells are frozen into portions of 10 million cells, a proper dose to inject into a tumor.

One of the advantages of Immunicum’s cancer vaccines is that the concept allows for large-scale production, thus facilitating access to treatment for more patients. The cancer vaccine has been tested in a pilot study in patients with metastatic renal cell cancer. The results are promising and show a prolonged median survival, but the patient population is still too small to allow reliable scientific conclusions. An additional study in patients with primary liver cancer is ongoing and a major European study will be initiated within short.

- Awarding Immunicum’s founder Alex Karlsson-Parra with this prestigious prize for clinical development emphasizes the innovation height of the vaccine projects that we are developing to improve the treatment of severely ill cancer patients, says Immunicum’s CEO Jamal El-Mosleh.

The prize, which consists of a research grant of 150 000 SEK, will be presented during the Swedish Society of Medicine’s National Conference on Thursday 4 December.

The motivation from the Athena Prize Jury:

"A creative and innovative approach in the development of therapeutic cancer vaccines that activates the patient's immune system to attack the tumor cells. By using immune cells from healthy donors, instead of from the patient himself, the method may give more severely ill cancer patients access to effective treatment. A thorough, persistent and challenging research work that stands on the verge of a major breakthrough. "

Media representatives are welcome to attend the award ceremony, taking place at 19.00 at the Swedish Society of Medicine’s premises on Klara Östra Kyrkogata 10 in Stockholm. Preregistration is made to Maja Florin, Project Manager of Athena Prize (maja.florin@dagensmedicin.se).

For further information, please contact:

Jamal El-Mosleh, CEO, Immunicum

Phone:  +46 31- 41 50 52,
jamal.el-mosleh@immunicum.com

Alex Karlsson-Parra, CSO, Immunicum

Phone: +46705-167579

Alex.karlsson-parra@immunicum.com

Johanna Adami, VINNOVA, Chairman of the Athena Prize Jury

Phone: +46 70-569 72 87

The Company’s Certified Adviser is Redeye AB

Phone: +46 8-545 013 31. www.redeye.se

About the Athena Prize

The principals of the Athena Prize are VINNOVA, the Swedish Research Council, Forte, Swedish Association of Local Authorities and Regions, LIF, Sweden Bio, Swedish Medtech and Dagens Medicin. The purpose of the prize is to recognize and reward major achievements in clinical research in Sweden. The jury's assessment criteria are medical benefits, level of innovation, urgency, scientific quality, social benefit and interaction between healthcare, academia and industry.

Om Immunicum AB (publ)

Immunicum AB (publ) develops vaccines for the treatment of tumor diseases. The company's most advanced project INTUVAX® is currently evaluated in a clinical phase I/II trial in patients with renal cancer. The project portfolio contains three further projects against various cancers, including liver cancer.

www.immunicum.se

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RayNeo's Black Friday Push Tests Smart Glasses Demand

Updated Category News Views 176

A million shipped pairs is a real milestone, but holiday markdowns are where the rubber meets the road for RayNeo. The company is taking its XR gaming glasses and iO AI smart glasses into Europe’s Black Friday scrum with discounts running through late November, betting that portability, giant virtual screens and a little AI convenience can pry open consumers’ wallets....

Continue Reading
Chemours Legal Succession Gets a Long Transition Runway

Updated Category News Views 85

A corporate-law handoff rarely sets pulses racing, but this one deserves a proper look. Chemours is replacing its long-serving general counsel while keeping the departing executive in the building for four additional months. That is not flashy, and thank goodness for that. In a global chemicals company, legal leadership touches regulation, compliance, governance,...

Continue Reading
Hone Health’s $228M Bet on Data-Led Longevity Care

Updated Category News Views 230

Longevity medicine just got a very large check and an even larger assignment. Hone Health says it has raised $228 million to push physician-led care beyond its roots in hormone optimization, and the split of that financing matters more than the celebrity names attached to it. Only $28 million is described as Series A equity; the other $200 million comes as growth...

Continue Reading
Century Complete Tests Conway Demand Near Myrtle Beach

Updated Category News Views 108

Ninety-four lots in Conway may not move Wall Street by themselves, but they can say plenty about the kind of buyer Century Communities is chasing. Century Complete is opening its model at Cates Bay Crossing on Nov. 21, 2026, with single-family homes starting in the $260s. In a housing market where affordability gets talked to death and rarely delivered cleanly, that...

Continue Reading
Resolve Adds Cahaba in Birmingham Pain-Care Expansion

Updated Category News Views 198

Pain-care consolidation has a peculiar way of looking tidy in a release and messy in the real world. Resolve Pain Solutions announced on November 18, 2026, that it has acquired Cahaba Pain and Spine Care, an established provider serving greater Birmingham, Alabama. On its face, this is a straightforward expansion move: buy a respected local practice, retain its physician...

Continue Reading
Pacific Surfliner Faces Thanksgiving Capacity Test

Updated Category News Views 122

Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...

Continue Reading
WYBOT's New Robots Push Hands-Free Pool Care in Lyon

Updated Category News Views 77

A pool robot climbing out of the water to dock itself is the sort of demo that makes people stop mid-aisle at a trade show. WYBOT brought precisely that kind of attention-grabber to Piscine Global Lyon 2026, running November 17–20 at Eurexpo Lyon. The company is showing a broader lineup, but the M3 Pro is plainly the headline act: WYBOT calls it the world's first...

Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps

Updated Category News Views 131

Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....

Continue Reading
Modexus Opens a $500 Million Buyback With Real Caveats

Updated Category News Views 155

A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...

Continue Reading
Precision Metal Forming Is Industry's Quiet Backbone

Updated Category News Views 205

A fraction of a millimeter can turn a perfectly good industrial part into an expensive headache. That unglamorous reality sits at the center of Michele Caulfield's discussion of precision metal forming for HelloNation, and it deserves more attention than it usually gets. Investors watching manufacturing tend to chase flashy automation headlines, big aerospace orders, or...

Continue Reading

Top 5 Most Recently Viewed Articles

Honda Motor Co. Reports Strong Q1 Results Amid Challenges

Updated Category News Views 247

Honda Motor Co.'s Recent Financial Outcomes Honda Motor Co., Ltd. has reported its consolidated financial results for the fiscal first quarter, which concluded on June 30, 2025. This announcement highlights the company’s financial performance amidst a challenging economic landscape. Analysts and stakeholders are keen to understand how these results impact future...

Continue Reading
Transforming Education: Launch of ArthurAI by MindHYVE.ai™

Updated Category News Views 199

MindHYVE.ai™ and TechMindset Africa Unveil ArthurAI MindHYVE.ai™ and TechMindset Africa recently marked a significant moment by launching ArthurAI, a pioneering AGI-powered education platform. This innovative initiative embodies their commitment to transforming the educational landscape throughout the African continent. Strategic Partnership for Education The launch...

Continue Reading
Metagenomi Insiders Under Fire: Shareholder Concerns

Updated Category News Views 71

Unpacking the Heat at Metagenomi Picture this—you're sitting on the edge of your investment seat, holding stock in Metagenomi Therapeutics, Inc. (NASDAQ:MGX), and suddenly, there's a bombshell. Halper Sadeh LLC, an outfit that's no stranger to rattling corporate cages, has its sights set on whether the bigwigs at Metagenomi breached their fiduciary duties. Now, if...

Continue Reading
KBR Inc. Unveils Bold Spin-Off Strategy for Growth

Updated Category News Views 302

KBR Inc. Unveils Its Plan to Spin Off Mission Technology Solutions KBR, Inc. announced that its board of directors has adopted a comprehensive strategy to spin off its Mission Technology Solutions business. This significant move aims to separate the company into two distinct public entities, which is expected to be realized in a tax-free transaction targeted for...

Continue Reading
Waters Corporation Plans Upcoming Earnings Call for Q3 2025

Updated Category News Views 198

Waters Corporation Announces Q3 2025 Earnings Conference Call Waters Corporation (NYSE: WAT) is set to hold an important conference call aimed at discussing its financial results for the third quarter of 2025. This event is scheduled for early November. The company has a strong reputation for transparency and is committed to engaging with its investors. Details of the...

Continue Reading